TEC Assessments in Press

January 2010

The following Assessments and Special Report from the October 2009 Medical Advisory Panel (MAP) meeting are in press.

• Angioplasty and Stenting of the Cervical Carotid Artery with Embolic Protection of the Cerebral Circulation
• Special Report: Vaccines for the Treatment of Prostate Cancer
• Pharmacogenetic Testing to Predict Serious Toxicity from 5-Fluorouracil (5-FU) for Patients Administered 5-FU-Based Chemotherapy for Cancer

Please note that the draft, “Laboratory Testing to Allow Area Under the Curve (AUC) -Targeted 5-Fluorouracil Dosing for Patients Administered Chemotherapy for Cancer,” was tabled for revision and action at the December meeting.

September 2009

The following Special Report from the June 2009 Medical Advisory Panel (MAP) meeting is in press.

• Special Report: Evaluating Evidence Supporting a Role for Genetic Markers in Diagnosis, Determining Disease Predisposition, Prognosis, or Predicting Therapeutic Response

_____________________________________________________________________

NOTICE OF PURPOSE:  TEC Assessments are scientific opinions, provided solely for informational purposes. TEC Assessments should not be construed to suggest that the Blue Cross Blue Shield Association, Kaiser Permanente Medical Care Program or the TEC Program recommends, advocates, requires, encourages, or discourages any particular treatment, procedure, or service; any particular course of treatment, procedure, or service; or the payment or non-payment of the technology or technologies evaluated.